Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia

Angelo M. Carella, Paolo Carlier, Ester Pungolino, Luigi Resegotti, Vincenzo Liso, Roberto Stasi, Marco Montillo, Pasquale Iacopino, Salvatore Mirto, Livio Pagano, Franco Leoni, Fabrizio M. Martelli, Francesco Di Raimondo, Adolfo Porcellini, Luigi De Riu, Anna M. Nosari, Renato Cimino, Eugenio Damasio, Eustachio Miraglia, Giuseppe FioritoniFrancesco Ricciuti, Mario Carotenuto, Maurizio Longinotti, Daniela Defazio, Paola Fazi, Franco Mandelli

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Idarubicin in combination with intermediate-dose cytarabine and VP-16 in the treatment of refractory or rapidly relapsed patients with acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences